News thumbnail
Science / Sun, 24 May 2026 Nature

EpCAM-targeted ZIF-8 nanocarriers for enhanced doxorubicin delivery in cancer therapy: a promising approach for tumor-specific drug release

Competing interestsThe authors declare no competing interests. All methods are reported in accordance with the ARRIVE guidelines (https://arriveguidelines.org), ensuring high standards of animal welfare and reproducibility. Use of AI toolsNo generative AI or AI-assisted tools were used to create, modify, or process any figures, images, or artwork in this manuscript. AI-based tools, where used, were limited to minor grammar and language editing and did not alter the scientific content or conclusions. The scientific content and conclusions are solely the responsibility of the authors

Competing interests

The authors declare no competing interests.

Ethical statement

All animal experiments were performed in accordance with the relevant guidelines and regulations of Baqiyatallah University of Medical Sciences and were approved by its Research Ethics Committee (Approval ID: IR.BMSU.BLC.1403.113). All methods are reported in accordance with the ARRIVE guidelines (https://arriveguidelines.org), ensuring high standards of animal welfare and reproducibility.

Use of AI tools

No generative AI or AI-assisted tools were used to create, modify, or process any figures, images, or artwork in this manuscript. AI-based tools, where used, were limited to minor grammar and language editing and did not alter the scientific content or conclusions. The scientific content and conclusions are solely the responsibility of the authors

© All Rights Reserved.